Paracrine secretion of transforming growth factor-β1 in aneurysm healing and stabilization with endovascular smooth muscle cell therapy

Journal of Vascular Surgery

Volumn 37, Issue 6, 2003, Pages 1301-1309

  Losy, Franck ^a   Dai, Jianping ^a   Pages, Carine ^a   Ginat, Maryvonne ^a   Muscatelli Groux, Béatrice ^a   Guinault, Anne Marie ^a   Rousselle, Elodie ^a   Smedile, Gianluca ^b   Loisance, Daniel ^a   Becquemin, Jean Pierre ^a   Allaire, Eric ^a,b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL TENON   (France)

^c Centre de Recherches Chirurgicales   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA;

ABDOMINAL AORTA ANEURYSM; ADOPTIVE IMMUNOTHERAPY; ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GUINEA PIG; INTIMA; MALE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBUS; VASCULAR SMOOTH MUSCLE; WOUND HEALING; XENOGRAFT; ANIMAL; BIOLOGICAL THERAPY; DISEASE MODEL; FISCHER 344 RAT; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOOTH MUSCLE FIBER;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; DISEASE MODELS, ANIMAL; GENE EXPRESSION; MALE; MYOCYTES, SMOOTH MUSCLE; PARACRINE COMMUNICATION; RATS; RATS, INBRED F344; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TISSUE THERAPY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 0037734184     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(02)75336-6     Document Type: Article

References (45)

1. Allaire E, Muscatelli-Groux B, Guinault A-M, Pagès C, Goussard A, Mandet C, et al. Vascular smooth muscle cell endovascular therapy stabilizes dilated aortas injured by inflammation and proteolysis in a xenograft model. Ann Surg. In Press 2003.
2. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000;342:1350-8.
3. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB. Latent transforming growth fictor-beta: Structural features and mechanisms of activation. Kidney Int 1997;51:1376-82.
4. Derynck R, Zhang Y, Feng XH. Smads: Transcriptional activators of TGF-beta responses. Cell 1998;95:737-40.
5. Bobik A, Agrotis A, Kanellakis P, Dilley R, Krushinsky A, Smirnov V, et al. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions: Colocalization implicates TGF-beta in fibrofatty lesion development. Circulation 1999;99:2883-91.
6. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor β-1 during repair of arterial injury. J Clin Invest 1991;88:904-10.
7. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108:985-1002.
8. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999;104:1191-97.
9. Allaire E, Guettier C, Michel JB. Cell-free arterial grafts: Morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg 1994;19:446-56.
10. Battle T, Arnal JF, Challah M, Michel JB. Selective isolation of rat aortic wall layers and their cell types in culture: Application to converting enzyme activity measurement. Tissue Cell 1994;26:943-55.
11. Ernst CB. Abdominal aortic aneurysm. N Engl J Med 1993;328:1167-72.
12. Allaire E, Forough R, Clowes MM, Starcher B, Clowes AW. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 1998;102:1413-20.
13. Roberts AB, Lamb LC, Newton DL, Sporn MB, De Larco JE, Todd GJ. Transforming growth factors: Isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci USA 1980;77:3494-8.
14. Gautier C, Levacher C, Avallet O, Vigier M, Rouiller-Fabre V, Lecerf L, et al. Immunohistochemical localization of transforming growth factor-beta 1 in the fetal and neonatal rat testis. Mol Cell Endocrinol 1994;99:55-61.
15. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-9.
16. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
17. Golledge J, Greenhalgh RM, Davies AH. The symptomatic carotid plaque. Stroke 2000;31:774-81.
18. Shah PK. Inflammation, metalloproteinases, and increased proteolysis: An emerging pathophysiological paradigm in aortic aneurysm. Circulation 1997;96:2115-7.
19. Carmeliet P. Proteinases in cardiovascular aneurysms and rupture: Targets for therapy. J Clin Invest 2000;105:1519-20.
20. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet 1998;352:1649-55.
21. 1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation 2001;71:1463-67.
22. Biggart S, Chin D, Fauchon M, Cardew G, du FL, Harker N, et al. Association of genetic polymorphisms in the ACE, ApoE, and TGF beta genes with early onset ischemic heart disease. Clin Cardiol 1998;21:831-6.
23. 1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci U S A 1998;95:6983-8.
24. Nabel EG, Shum L, Pompili VJ, Yang ZY, San H, Shu HB, et al. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA 1993;90:10759-63.
25. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000;14:163-76.
26. Lyons RM, Gentry LE, Purchio AF, Moses HL. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol 1990;110:1361-7.
27. Allaire E, Hasenstab D, Kenagy R, Clowes MM, Starcher B, Clowes AW. Overpression of plasminogen activator-inhibitor prevents arterial extracellular matrix degradation by blocking matrix metalloproteinase activity. Circulation 1998;98:249-55.
28. Larsson J, Goumans MJ, Sjostrand LJ, van Rooijen MA, Ward D, Leveen P, et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type 1 receptor-deficient mice. EMBO J 2001;20:1663-73.
29. Farrehi PM, Ozaki CK, Carmeliet P, Fay WP. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation 1998;97:1002-8.
30. Overall CM, Wrana JL, Sodek J. Independant regulation of collagenase, 72-kD progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J Biol Chem 1989;264:1860-9.
31. Vaday GG, Schor H, Rahat MA, Lahat N, Lider O. Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes. J Leukoc Biol 2001;69:613-21.
32. Lund LR, Riccio A, Andreasen PA, Nielsen LS, Kristensen P, Laiho M, et al. Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J 1987;6:1281-6.
33. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998;16:137-61.
34. Shanley CJ, Gharaee-Kermani M, Sarkar R, Welling TH, Kriegel A, Ford JW, et al. Transforming growth factor-beta 1 increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells. J Vasc Surg 1997;25:446-52.
35. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, et al. Transforming growth factor b1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;90:770-4.
36. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, et al. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999;145:33-43.
37. 1 reduce transplant arteriosclerosis: Insight derived from a knockout mouse model. Circ Res 1998;83:652-60.
38. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Natl Med 1995;1:932-7.
39. 1 gene ablation in murine embryonic fibroblasts: Autocrine control of cell proliferation and extracellular matrix biosynthesis. J Cell Physiol 1998;176:67-75.
40. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5:491-9.
41. Riser BL, Cortes P, Heilig C, Grondin J, Ladson-Wofford S, Patterson D, et al. Cyclic stretching force selectively up-regulates transforming growth factor-beta isoforms in cultured rat mesangial cells. Am J Pathol 1996;148:1915-23.
42. O'Callaghan CJ, Williams B. Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: Role of TGF-beta(1). Hypertension 2000;36:319-24.
43. Li Q, Muragaki Y, Hatamura I, Ueno H, Ooshima A. Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and transforming growth factor-beta. J Vasc Res 1998;35:93-103.
44. Allaire E, Mandet C, Bruneval P, Bensenane S, Becquemin JP, Michel JB. Cell and extracellular matrix rejection in arterial concordant and discordant xenografts in rat. Transplantation 1996;62:794-803.
45. Allaire E, Muscatelli-Groux B, Mandet C, Guinault A-M, Bruneval P, Desgranges P, et al. Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation. J Vasc Surg 2002;36:1018-26.